-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Generation Bio, Maintains $8 Price Target

Benzinga·05/08/2025 11:56:24
Listen to the news
Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $8 price target.